Cargando…
Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood
SIMPLE SUMMARY: Detection of circulating tumor cells (CTCs) in blood can be used to diagnose cancer or monitor treatment response for various cancers. However, these cells are rare in the bloodstream in the early stages of cancers, and it, therefore, remains a technical challenge to isolate them. To...
Autores principales: | Geus, Paul Friedrich, Hehnen, Felix, Krakowski, Sophia, Lücke, Klaus, Hoon, Dave S. B., Frost, Nikolaj, Kertzscher, Ulrich, Wendt, Gabi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562020/ https://www.ncbi.nlm.nih.gov/pubmed/36230675 http://dx.doi.org/10.3390/cancers14194753 |
Ejemplares similares
-
Recent Update Roles of Magnetic Nanoparticles in Circulating Tumor Cell (CTC)/Non-CTC Separation
por: Pipatwatcharadate, Chawapon, et al.
Publicado: (2023) -
miRNA in situ hybridization in circulating tumor cells - MishCTC
por: Ortega, Francisco G., et al.
Publicado: (2015) -
Aneuploid CTC and CEC
por: Lin, Peter Ping
Publicado: (2018) -
How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring
por: Zeune, Leonie L., et al.
Publicado: (2018) -
Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
por: Perumal, Vanathi, et al.
Publicado: (2019)